Herbas VPB

Print
EN | LT
LT - Proliferacinių sutrikimų ir kitų patologinių būklių, medijuojamų Bcr-Abl, c-Kit, DDR1, DDR2 arba PDGF-R kinazės aktyvumo, gydymo būdas
EN - METHOD OF TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R KINASE ACTIVITY

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/506 (2006.01)
A61P 35/00 (2006.01)
A61K 9/00 (2006.01)
C07D 239/69 (2006.01)
European patent
(11) Number of the document 2501384
(13) Kind of document T
(96) European patent application number 10781781.9
Date of filing the European patent application 2010-11-17
(97) Date of publication of the European application 2012-09-26
(45) Date of publication and mention of the grant of the patent 2016-02-17
(46) Date of publication of the claims translation 2016-05-10
PCT application
(86) Number PCT/US2010/056926
Date 2010-11-17
PCT application publication
(87) Number WO 2011/062927
Date 2011-05-26
Priority applications
(30) Number Date Country code
261812 P 2009-11-17 US
Inventors
(72)
GALLAGHER, Neil, CH
YIN, Ophelia, US
Grantee
(73) Novartis AG, Lichtstrasse 35, 4056 Basel, CH
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Proliferacinių sutrikimų ir kitų patologinių būklių, medijuojamų Bcr-Abl, c-Kit, DDR1, DDR2 arba PDGF-R kinazės aktyvumo, gydymo būdas
  METHOD OF TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R KINASE ACTIVITY
Last renewal fee
Payment date Validity (years) Amount
2024-10-21 15 289.00 EUR
Next renewal fee
2025-11-17